Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 685 to 688 of 688 entries
Sorted by: Best Match Show Resources per page
Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice.

Amyotrophic lateral sclerosis & frontotemporal degeneration

Palmer J, Messer B, Ramsay M.
PMID: 33969757
Amyotroph Lateral Scler Frontotemporal Degener. 2021 May 08;1-7. doi: 10.1080/21678421.2021.1916534. Epub 2021 May 08.

No abstract available.

Cite
Palmer J, Messer B, Ramsay M. Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice. Amyotroph Lateral Scler Frontotemporal Degener. 2021;1-7doi: 10.1080/21678421.2021.1916534.
Palmer, J., Messer, B., & Ramsay, M. (2021). Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice. Amyotrophic lateral sclerosis & frontotemporal degeneration, 1-7. https://doi.org/10.1080/21678421.2021.1916534
Palmer, Jonathan, et al. "Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice." Amyotrophic lateral sclerosis & frontotemporal degeneration vol. (2021): 1-7. doi: https://doi.org/10.1080/21678421.2021.1916534
Palmer J, Messer B, Ramsay M. Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice. Amyotroph Lateral Scler Frontotemporal Degener. 2021 May 08;1-7. doi: 10.1080/21678421.2021.1916534. Epub 2021 May 08. PMID: 33969757.
Copy Download .nbib Format: NLM
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.

Nature communications

Amirthalingam G, Bernal JL, Andrews NJ, Whitaker H, Gower C, Stowe J, Tessier E, Subbarao S, Ireland G, Baawuah F, Linley E, Warrener L, O'Brien M, Whillock C, Moss P, Ladhani SN, Brown KE, Ramsay ME.
PMID: 34893611
Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5.

The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca) vaccines by extending the interval between doses up to 12 weeks. In 750 participants aged 50-89 years, we here compare serological responses after BNT162b2 and...

Cite
Amirthalingam G, Bernal JL, Andrews NJ, et al. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nat Commun. 2021;12(1):7217doi: 10.1038/s41467-021-27410-5.
Amirthalingam, G., Bernal, J. L., Andrews, N. J., Whitaker, H., Gower, C., Stowe, J., Tessier, E., Subbarao, S., Ireland, G., Baawuah, F., Linley, E., Warrener, L., O'Brien, M., Whillock, C., Moss, P., Ladhani, S. N., Brown, K. E., & Ramsay, M. E. (2021). Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nature communications, 12(1), 7217. https://doi.org/10.1038/s41467-021-27410-5
Amirthalingam, Gayatri, et al. "Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England." Nature communications vol. 12,1 (2021): 7217. doi: https://doi.org/10.1038/s41467-021-27410-5
Amirthalingam G, Bernal JL, Andrews NJ, Whitaker H, Gower C, Stowe J, Tessier E, Subbarao S, Ireland G, Baawuah F, Linley E, Warrener L, O'Brien M, Whillock C, Moss P, Ladhani SN, Brown KE, Ramsay ME. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5. PMID: 34893611.
Copy Download .nbib Format: NLM
Evolutionary genomics in Africa.

Human molecular genetics

Ramsay M, Schlebusch C, Davies K.
PMID: 33899913
Hum Mol Genet. 2021 Apr 26;30:R1. doi: 10.1093/hmg/ddab030.

No abstract available.

Cite
Ramsay M, Schlebusch C, Davies K. Evolutionary genomics in Africa. Hum Mol Genet. 2021;30:R1doi: 10.1093/hmg/ddab030.
Ramsay, M., Schlebusch, C., & Davies, K. (2021). Evolutionary genomics in Africa. Human molecular genetics, 30R1. https://doi.org/10.1093/hmg/ddab030
Ramsay, Michèle, et al. "Evolutionary genomics in Africa." Human molecular genetics vol. 30 (2021): R1. doi: https://doi.org/10.1093/hmg/ddab030
Ramsay M, Schlebusch C, Davies K. Evolutionary genomics in Africa. Hum Mol Genet. 2021 Apr 26;30:R1. doi: 10.1093/hmg/ddab030. PMID: 33899913.
Copy Download .nbib Format: NLM
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.

Nature communications

Amirthalingam G, Bernal JL, Andrews NJ, Whitaker H, Gower C, Stowe J, Tessier E, Subbarao S, Ireland G, Baawuah F, Linley E, Warrener L, O'Brien M, Whillock C, Moss P, Ladhani SN, Brown KE, Ramsay ME.
PMID: 34893611
Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5.

The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca) vaccines by extending the interval between doses up to 12 weeks. In 750 participants aged 50-89 years, we here compare serological responses after BNT162b2 and...

Cite
Amirthalingam G, Bernal JL, Andrews NJ, et al. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nat Commun. 2021;12(1):7217doi: 10.1038/s41467-021-27410-5.
Amirthalingam, G., Bernal, J. L., Andrews, N. J., Whitaker, H., Gower, C., Stowe, J., Tessier, E., Subbarao, S., Ireland, G., Baawuah, F., Linley, E., Warrener, L., O'Brien, M., Whillock, C., Moss, P., Ladhani, S. N., Brown, K. E., & Ramsay, M. E. (2021). Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nature communications, 12(1), 7217. https://doi.org/10.1038/s41467-021-27410-5
Amirthalingam, Gayatri, et al. "Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England." Nature communications vol. 12,1 (2021): 7217. doi: https://doi.org/10.1038/s41467-021-27410-5
Amirthalingam G, Bernal JL, Andrews NJ, Whitaker H, Gower C, Stowe J, Tessier E, Subbarao S, Ireland G, Baawuah F, Linley E, Warrener L, O'Brien M, Whillock C, Moss P, Ladhani SN, Brown KE, Ramsay ME. Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5. PMID: 34893611.
Copy Download .nbib Format: NLM
Showing 685 to 688 of 688 entries